CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-14
DOI
10.1038/s41419-019-2012-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function
- (2018) You-Take Oh et al. ONCOGENE
- M1 Macrophages Are Predominantly Recruited to the Major Pelvic Ganglion of the Rat Following Cavernous Nerve Injury
- (2017) Hotaka Matsui et al. Journal of Sexual Medicine
- Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
- (2017) S V Glavey et al. LEUKEMIA
- Ccl2/Ccr2 signalling recruits a distinct fetal microchimeric population that rescues delayed maternal wound healing
- (2017) Mathieu Castela et al. Nature Communications
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis
- (2016) Harini Raghu et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
- (2016) A. Gutierrez-Gonzalez et al. BLOOD
- Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Anusha Kalbasi et al. CLINICAL CANCER RESEARCH
- Progress and Paradigms in Multiple Myeloma
- (2016) Kenneth C. Anderson CLINICAL CANCER RESEARCH
- Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
- (2016) Anne-Laure Chéné et al. Journal of Thoracic Oncology
- Metabolic reprogramming in macrophages and dendritic cells in innate immunity
- (2015) Beth Kelly et al. CELL RESEARCH
- CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
- (2015) S. Svensson et al. CLINICAL CANCER RESEARCH
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment
- (2015) Christopher G. Peña et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcription Factors STAT6 and KLF4 Implement Macrophage Polarization via the Dual Catalytic Powers of MCPIP
- (2015) Nidhi Kapoor et al. JOURNAL OF IMMUNOLOGY
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL
- (2014) Tetsuro Ohba et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Adenosine 5'-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
- (2014) D. Sag et al. JOURNAL OF IMMUNOLOGY
- Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
- (2014) Irene Brana et al. Targeted Oncology
- USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO
- (2013) Jixiao Niu et al. EMBO JOURNAL
- Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway
- (2012) Pappachan E. Kolattukudy et al. CIRCULATION RESEARCH
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma
- (2012) Y Zheng et al. LEUKEMIA
- MCP-1-induced protein-1, an immune regulator
- (2012) Jiwei Xu et al. Protein & Cell
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now